ipsas 29—financial instruments: recognition and measurement - IFAC
ipsas 29—financial instruments: recognition and measurement - IFAC
ipsas 29—financial instruments: recognition and measurement - IFAC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FINANCIAL INSTRUMENTS: RECOGNITION AND MEASUREMENT<br />
borrowers. In such cases, an entity uses its experienced judgment to estimate the<br />
amount of any impairment loss. Similarly an entity uses its experienced judgment<br />
to adjust observable data for a group of financial assets to reflect current<br />
circumstances (see paragraph AG122). The use of reasonable estimates is an<br />
essential part of the preparation of financial statements <strong>and</strong> does not undermine<br />
their reliability.<br />
Financial Assets Carried at Amortized Cost<br />
72. If there is objective evidence that an impairment loss on loans <strong>and</strong><br />
receivables or held-to-maturity investments carried at amortized cost has<br />
been incurred, the amount of the loss is measured as the difference between<br />
the asset’s carrying amount <strong>and</strong> the present value of estimated future cash<br />
flows (excluding future credit losses that have not been incurred) discounted<br />
at the financial asset’s original effective interest rate (i.e., the effective interest<br />
rate computed at initial <strong>recognition</strong>). The carrying amount of the asset shall<br />
be reduced either directly or through use of an allowance account. The<br />
amount of the loss shall be recognized in surplus or deficit.<br />
73. An entity first assesses whether objective evidence of impairment exists<br />
individually for financial assets that are individually significant, <strong>and</strong> individually<br />
or collectively for financial assets that are not individually significant (see<br />
paragraph 68). If an entity determines that no objective evidence of impairment<br />
exists for an individually assessed financial asset, whether significant or not, it<br />
includes the asset in a group of financial assets with similar credit risk<br />
characteristics <strong>and</strong> collectively assesses them for impairment. Assets that are<br />
individually assessed for impairment <strong>and</strong> for which an impairment loss is or<br />
continues to be recognized are not included in a collective assessment of<br />
impairment.<br />
74. If, in a subsequent period, the amount of the impairment loss decreases <strong>and</strong><br />
the decrease can be related objectively to an event occurring after the<br />
impairment was recognized (such as an improvement in the debtor’s credit<br />
rating), the previously recognized impairment loss shall be reversed either<br />
directly or by adjusting an allowance account. The reversal shall not result in<br />
a carrying amount of the financial asset that exceeds what the amortized cost<br />
would have been had the impairment not been recognized at the date the<br />
impairment is reversed. The amount of the reversal shall be recognized in<br />
surplus or deficit.<br />
Financial Assets Carried at Cost<br />
75. If there is objective evidence that an impairment loss has been incurred on<br />
an unquoted equity instrument that is not carried at fair value because its<br />
fair value cannot be reliably measured, or on a derivative asset that is linked<br />
to <strong>and</strong> must be settled by delivery of such an unquoted equity instrument, the<br />
amount of the impairment loss is measured as the difference between the<br />
IPSAS 29 1054